Mesirow Financial Investment Management Equity & Fixed Income Pacira Bio Sciences, Inc. Transaction History

Mesirow Financial Investment Management Equity & Fixed Income

$97.3 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$51.49 - $81.64 $3.46 Million - $5.49 Million	-67,270 Reduced 32.31%	140,927 $8.22 Million
Q1 2022 May 09, 2022	SELL	$60.03 - $76.49 $2,701 - $3,442	-45 Reduced 0.02%	208,197 $15.9 Million
Q4 2021 Feb 07, 2022	SELL	$47.97 - $62.21 $126,400 - $163,923	-2,635 Reduced 1.25%	208,242 $12.5 Million
Q3 2021 Nov 04, 2021	SELL	$54.64 - $61.3 $67,480 - $75,705	-1,235 Reduced 0.58%	210,877 $11.8 Million
Q2 2021 Aug 03, 2021	BUY	$59.18 - $69.99 $5.44 Million - $6.43 Million	91,880 Added 76.42%	212,112 $12.9 Million
Q1 2021 May 03, 2021	SELL	$59.31 - $78.82 $1.42 Million - $1.89 Million	-23,995 Reduced 16.64%	120,232 $8.43 Million
Q4 2020 Feb 01, 2021	BUY	$50.47 - $66.26 $793,640 - $1.04 Million	15,725 Added 12.24%	144,227 $8.63 Million
Q3 2020 Nov 05, 2020	BUY	$51.97 - $63.0 $147,854 - $179,235	2,845 Added 2.26%	128,502 $7.73 Million
Q2 2020 Aug 06, 2020	SELL	$30.8 - $52.47 $749,518 - $1.28 Million	-24,335 Reduced 16.22%	125,657 $6.59 Million
Q1 2020 Apr 28, 2020	BUY	$28.4 - $50.7 $1.35 Million - $2.41 Million	47,581 Added 46.46%	149,992 $5.03 Million
Q4 2019 Feb 04, 2020	SELL	$36.31 - $46.83 $691,887 - $892,345	-19,055 Reduced 15.69%	102,411 $4.64 Million
Q3 2019 Oct 31, 2019	BUY	$35.66 - $44.99 $422,749 - $533,356	11,855 Added 10.82%	121,466 $4.62 Million
Q2 2019 Jul 30, 2019	BUY	$36.57 - $47.97 $720,063 - $944,529	19,690 Added 21.9%	109,611 $4.77 Million
Q1 2019 May 13, 2019	SELL	$36.47 - $42.17 $2.36 Million - $2.73 Million	-64,815 Reduced 41.89%	89,921 $3.42 Million
Q4 2018 Feb 05, 2019	SELL	$41.31 - $52.16 $1.29 Million - $1.63 Million	-31,170 Reduced 16.77%	154,736 $6.66 Million
Q3 2018 Oct 29, 2018	SELL	$32.85 - $52.0 $1.77 Million - $2.79 Million	-53,735 Reduced 22.42%	185,906 $9.14 Million
Q2 2018 Aug 02, 2018	SELL	$27.5 - $39.8 $1.85 Million - $2.67 Million	-67,145 Reduced 21.89%	239,641 $7.68 Million
Q1 2018 May 09, 2018	SELL	$29.98 - $46.35 $3.11 Million - $4.81 Million	-103,775 Reduced 25.28%	306,786 $9.56 Million
Q4 2017 Jan 30, 2018	BUY	$31.85 - $46.95 $633,050 - $933,178	19,876 Added 5.09%	410,561 $18.7 Million
Q3 2017 Oct 30, 2017	BUY	$35.7 - $39.5 $13.9 Million - $15.4 Million	390,685	390,685 $14.7 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.

Account